Bought
Maintained
Sold
Other funds holding LH
VCM
VPM
Amundi's LH Position: Q1 2026 in Review
Amundi increased its Labcorp (LH) stake by 14% in Q1 2026, buying an estimated $9.3M and bringing the position to 274,184 shares worth $73.2M. The position accounts for 0.02% of the portfolio, ranked #513.
Amundi first reported a position in LH in Q2 2021 and has held it in 20 quarters since. The position peaked at $263M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Amundi held 274,184 shares of Labcorp worth $73.2M as of Q1 2026.
- Amundi bought 34,351 Labcorp shares in Q1 2026, an estimated $9.3M.
- Labcorp made up 0.02% of Amundi's portfolio in Q1 2026, its #513 holding.
- Amundi first reported a position in Labcorp in Q2 2021 and has held it in 20 quarters since.
- Amundi's Labcorp position peaked at $263M in Q4 2024.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.